Product image of Micofenolato De Mofetil Farmoz (Mycophenolate Mofetil) supplied by GNH India

Micofenolato De Mofetil Farmoz

Active Ingredient:
Mycophenolate Mofetil
Origin:
EU

Micofenolato De Mofetil Farmoz (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Micofenolato De Mofetil Farmoz, is an antimetabolite immunosuppressant presented as an oral tablet for systemic use. It is employed to prevent organ transplant rejection and to treat lupus nephritis by inhibiting lymphocyte proliferation in transplant recipients and patients with autoimmune kidney disease.

GNH India supplies Micofenolato De Mofetil Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manufacturer / TM Owner

Farmoz - Sociedade Técnico Medicinal, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mycophenolate Mofetil is used in immunosuppressive therapy to reduce immune‑mediated organ damage.

  • Kidney transplant: helps prevent rejection of the transplanted kidney.
  • Heart transplant: reduces risk of graft rejection in heart recipients.
  • Liver transplant: supports long‑term graft survival by suppressing immune response.
  • Lupus nephritis: improves renal outcomes by decreasing autoimmune inflammation.

How It Works

  • Mycophenolate Mofetil selectively and reversibly inhibits inosine monophosphate dehydrogenase (IMPDH), the key enzyme in the de novo synthesis of guanosine nucleotides. By blocking IMPDH, the drug depletes guanosine triphosphate pools required for DNA synthesis, preferentially affecting proliferating T and B lymphocytes that rely on this pathway, thereby suppressing immune activation.

Side Effects

Mycophenolate Mofetil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Gastrointestinal upset: nausea, vomiting, diarrhea, abdominal pain.
  • Headache: mild to moderate intensity.
  • Infections: increased susceptibility to common bacterial or viral infections.

Serious or Rare Side Effects

  • Severe opportunistic infection: e.g., Pneumocystis jirovecii pneumonia.
  • Progressive multifocal leukoencephalopathy (PML).
  • Bone marrow failure: aplastic anemia or severe pancytopenia.

Precautions & Warnings

When prescribing Mycophenolate Mofetil, several safety considerations are essential.

  • Pregnancy: contraindicated (Category X) due to risk of fetal toxicity.
  • Breastfeeding: not recommended because the drug is excreted in milk.
  • Renal impairment: dose may need adjustment; monitor renal function.
  • Hepatic impairment: use with caution; monitor liver enzymes.
  • Infection risk: screen for latent infections and consider prophylaxis.
  • Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Avoid Interactions

Mycophenolate Mofetil interacts with several medicines that may alter its efficacy or safety.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce mycophenolate absorption.
  • Live vaccines: increased risk of severe infection.
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): markedly lower drug exposure.

Moderate Interactions (Monitor Closely)

  • Azathioprine: additive bone‑marrow suppression; monitor blood counts.
  • NSAIDs: may increase risk of renal impairment when combined.

Frequently Asked Questions

Micofenolato De Mofetil Farmoz contains Mycophenolate Mofetil, an immunosuppressive agent prescribed to prevent rejection after organ transplantation (kidney, heart, liver) and to treat lupus nephritis by dampening abnormal immune activity.

Mycophenolate Mofetil inhibits the enzyme inosine monophosphate dehydrogenase (IMPDH), which is essential for de novo guanosine nucleotide synthesis. This blocks DNA replication in rapidly dividing T and B lymphocytes, reducing their proliferation and overall immune response.

The appropriate dose is determined by the prescribing clinician based on the patient’s condition, weight, renal function and other factors. Dosage regimens are individualized and should follow the prescriber’s instructions and local guidelines.

Mycophenolate Mofetil is classified as Pregnancy Category X because it can cause fetal malformations and embryotoxicity. It is also not recommended during breastfeeding, as the drug is excreted in milk and may affect the infant.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycophenolate Mofetil offers a distinct mechanism—selective IMPDH inhibition—differing from calcineurin inhibitors like cyclosporine or tacrolimus. It is often used in combination regimens and may have a more favorable side‑effect profile for certain patients, though individual response varies.

Store the product at ambient temperature below 25 °C. Keep it in the original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious risks include opportunistic infections such as Pneumocystis jirovecii pneumonia, progressive multifocal leukoencephalopathy (PML), severe bone‑marrow suppression leading to aplastic anemia, and rare but life‑threatening hypersensitivity reactions.

Patients who are pregnant, planning pregnancy, or breastfeeding should avoid the drug. It is also contraindicated in individuals with known hypersensitivity to Mycophenolate Mofetil or any of its excipients, and caution is required in those with severe renal or hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mycophenolate Mofetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT